SEC Company Response from Oric Pharmaceuticals, Inc. (ORIC) (CIK 0001796280) (ORIC) — Apr 21, 2020
Oric Pharmaceuticals, Inc. (ORIC) (CIK 0001796280)
Date: April 21, 2020 · CIK: 0001796280 · Accession: 0001193125-20-113496
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-236792
Letter
Re: ORIC Pharmaceuticals, Inc.
April 21, 2020
United States Securities and Exchange Commission Division of Corporation Finance
100 F Street, N.E. Washington, DC 20549
Attention: Jeffrey Gabor
Celeste Murphy
Ibolya Ignat
Kevin Vaughn
Registration Statement on Form S-1 (File No. 333-236792)
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between April 20, 2020 and the date hereof, approximately 425 copies of the Preliminary Prospectus dated April 20, 2020 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on April 23, 2020 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
J.P. MORGAN SECURITIES LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP April 21, 2020 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Jeffrey Gabor Celeste Murphy Ibolya Ignat Kevin Vaughn Re: ORIC Pharmaceuticals, Inc. Registration Statement on Form S-1 (File No. 333-236792) Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between April 20, 2020 and the date hereof, approximately 425 copies of the Preliminary Prospectus dated April 20, 2020 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement. We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on April 23, 2020 or as soon thereafter as practicable. [Signature page follows] Very truly yours, J.P. MORGAN SECURITIES LLC CITIGROUP GLOBAL MARKETS INC. JEFFERIES LLC As representatives of the Underwriters By: J.P. Morgan Securities LLC By: /s/ Benjamin Burdett Name: Benjamin Burdett Title: Managing Director By: Citigroup Global Markets Inc. By: /s/ Bradley Wolff Name: Bradley Wolff Title: Managing Director By: Jefferies LLC By: /s/ Michael Brinkman Name: Michael Brinkman Title: Managing Director